Cyclosporine Therapy in Patients with Transfusion-independent Non-severe Aplastic Anemia: A Retrospective Analysis
Author:
Affiliation:
1. Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan
2. Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, Japan
Publisher
Japanese Society of Internal Medicine
Subject
General Medicine,Internal Medicine
Link
https://www.jstage.jst.go.jp/article/internalmedicine/58/3/58_1372-18/_pdf
Reference16 articles.
1. 1. Kojima S, Hibi S, Kosaka Y, et al. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood 96: 2049-2054, 2010.
2. 2. Fuhrer M, Rampf U, Baumann I, et al. Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival. Blood 106: 2102-2104, 2005.
3. 3. Marsh J, Schrezenmeier H, Marin P, et al. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party. Blood 93: 2191-2195, 1999.
4. 4. Marsh JC, Ball SE, Darbyshire P, et al. Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol 123: 782-801, 2003.
5. 5. Scheinberg P, Young NS. How I treat acquired aplastic anemia. Blood 120: 1185-1196, 2012.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Aplasie médullaire acquise de l’enfant et de l’adulte jeune de moins de trente ans : expérience du service d’hématologie et d’oncologie pédiatrique de l’hôpital 20 Août de Casablanca;Bulletin du Cancer;2024-09
2. Efficacy, safety and prognosis analysis of oral cyclosporine immunosuppressive regimen in children with acquired non-severe aplastic anemia: 13 years’ experience from a children’s hematology center of China;2024-02-23
3. Measurable residual disease in chronic lymphocytic leukemia. Where do we stand?;Leukemia;2023-10-14
4. Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study;Leukemia;2023-10-04
5. Severe infections and renal dysfunction during immunosuppressive therapy with cyclosporine A for aplastic anemia;International Journal of Hematology;2022-06-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3